Thrombin induces expression of twist and cell motility via the hypoxia-inducible factor-1α translational pathway in colorectal cancer cells

Journal of Cellular Physiology

Volumn 226, Issue 4, 2011, Pages 1060-1068

  Chang, Li Hsun ^a   Chen, Chun Han ^a   Huang, Der Yi ^a   Pai, Hui Chen ^a   Pan, Shiow Lin ^a,b   Teng, Che Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; NERVE CELL ADHESION MOLECULE; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; TRANSCRIPTION FACTOR TWIST;

ARTICLE; CANCER CELL; CELL MOTILITY; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; JACOBSEN SYNDROME; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

CADHERINS; CELL MOVEMENT; COLORECTAL NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, PAR-1; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; THROMBIN; TOR SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC; TWIST TRANSCRIPTION FACTOR;

EID: 79251515143     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22428     Document Type: Article

References (39)

1. Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, White RH. 2006. Venous thromboembolism in patients with colorectal cancer: Incidence and effect on survival. J Clin Oncol 24:1112-1118.
2. Archiniegas E, Neves CY, Candelle D, Cardier JE. 2004. Thrombin and its protease-activated receptor-1 (PAR1) participate in the endothelial-mesenchymal transdifferentiation process. DNA Cell Biol 23:815-825.
3. Black PC, Mize GJ, Karlin P, Greenberg DL, Hawley SJ, True LD, Vessella RL, Takayama TK. 2007. Overexpression of protease-activated receptors-1, -2, and-4 (PAR-1, -2, and -4) in prostate cancer. Prostate 67:743-756.
4. Chiang HS, Yang RS, Lin SW, Huang TF. 1998. Tissue factor activity of SW-480 human colon adenocarcinoma cells is modulated by thrombin and protein kinase C activation. Br J Cancer 78:1121-1127.
5. Coughlin SR. 2000. Thrombin signalling and protease-activated receptors. Nature 407:258-264.
6. D'Andrea MR, Derian CK, Santulli RJ, Andrade-Gordon P. 2001. Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues. Am J Pathol 158:2031-2041.
7. Dang DT, Chen F, Gardner LB, Cummins JM, Rago C, Bunz F, Kantsevoy SV, Dang LH. 2006. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts. Cancer Res 66:1684-1936.
8. Darmoul D, Gratio V, Devaud H, Lehy T, Laburthe M. 2003. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am J Pathol 162:1503-1513.
9. Darmoul D, Gratio V, Devaud H, Peiretti F, Laburthe M. 2004. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol Cancer Res 2:514-522.
10. Denko NC, Giaccia AJ. 2001. Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis. Cancer Res 61:795-798.
11. Diebold I, Djordjevic T, Hess J, Gorlach A. 2008. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: Role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription. Thromb Haemost 100:1021-1028.
12. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I, Bar-Shavit R. 1998. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 4:909-914.
13. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. 2008. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:381S-453S.
14. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, Busse R. 2001. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ Res 89:47-54.
15. Gratio V, Walker F, Lehy T, Laburthe M, Darmoul D. 2009. Aberrant expression of proteinase-activated receptor 4 promotes colon cancer cell proliferation through a persistent signaling that involves Src and ErbB-2 kinase. Int J Cancer 124:1517-1525.
16. Hu L, Roth JM, Brooks P, Ibrahim S, Karpatkin S. 2008. Twist is required for thrombin-induced tumor angiogenesis and growth. Cancer Res 68:4296-4302.
17. Jiang X, Zhu S, Panetti TS, Bromberg ME. 2008. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells. Thromb Haemost 100:127-133.
18. Kang Y, Massague J. 2004. Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 118:277-279.
19. Karni R, Dor Y, Keshet E, Meyuhas O, Levitzki A. 2002. Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1alpha expression under normoxia. J Biol Chem 277:42919-42925.
20. Kaushal V, Kohli M, Dennis RA, Siegel ER, Chiles WW, Mukunyadzi P. 2006. Thrombin receptor expression is upregulated in prostate cancer. Prostate 66:273-282.
21. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, Semenza GL. 2003. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63:1138-1143.
22. Liu J, Bastian M, Kohlschein P, Schuff-Werner P, Steiner M. 2003. Expression of functional protease-activated receptor 1 in human prostate cancer cell lines. Urol Res 31:163-168.
23. Liu J, Schuff-Werner P, Steiner M. 2006. Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells. Biochem Biophys Res Commun 343:183-189.
24. Massi D, Naldini A, Ardinghi C, Carraro F, Franchi A, Paglierani M, Tarantini F, Ketabchi S, Cirino G, Hollenberg MD, Geppetti P, Santucci M. 2005. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma. Hum Pathol 36:676-685.
25. Nierodzik ML, Karpatkin S. 2006. Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10:355-362.
26. Ossovskaya VS, Bunnett NW. 2004. Protease-activated receptors: Contribution to physiology and disease. Physiol Rev 84:579-621.
27. Rankin EB, Giaccia AJ. 2008. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15:678-685.
28. Richard DE, Berra E, Pouyssegur J. 2000. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 275:26765-26771.
29. Rosivatz E, Becker I, Bamba M, Schott C, Diebold J, Mayr D, Hofler H, Becker KF. 2004. Neoexpression of N-cadherin in E-cadherin positive colon cancers. Int J Cancer 111:711-719.
30. Semenza GL. 2003. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732.
31. Snyder KM, Kessler CM. 2008. The pivotal role of thrombin in cancer biology and tumorigenesis. Semin Thromb Hemost 34:734-741.
32. Tellez C, Bar-Eli M. 2003. Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene 22:3130-3137.
33. Thiery JP, Sleeman JP. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142.
34. Valdes-Mora F, Gomez del Pulgar T, Bandres E, Cejas P, Ramirez de Molina A, Perez-Palacios R, Gallego-Ortega D, Garcia-Cabezas MA, Casado E, Larrauri J, Nistal M, Gonzalez-Baron M, Garcia-Foncillas J, Lacal JC. 2009. TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer. Ann Surg Oncol 16:78-87.
35. Varki A. 2007. Trousseau's syndrome: Multiple definitions and multiple mechanisms. Blood 110:1723-1729.
36. Villares GJ, Zigler M, Wang H, Melnikova VO, Wu H, Friedman R, Leslie MC, Vivas-Mejia PE, Lopez-Berestein G, Sood AK, Bar-Eli M. 2008. Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. Cancer Res 68:9078-9086.
37. Wun T, White RH. 2009. Venous thromboembolism (VTE) in patients with cancer: Epidemiology and risk factors. Cancer Invest 27:63-74.
38. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927-939.
39. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC, Wu KJ. 2008. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10:295-305.